225 related articles for article (PubMed ID: 25425262)
1. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.
Lai JP; Conley A; Knudsen BS; Guindi M
Histopathology; 2015 Oct; 67(4):442-50. PubMed ID: 25425262
[TBL] [Abstract][Full Text] [Related]
2. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.
Zen C; Zen Y; Mitry RR; Corbeil D; Karbanová J; O'Grady J; Karani J; Kane P; Heaton N; Portmann BC; Quaglia A
Liver Transpl; 2011 Aug; 17(8):943-54. PubMed ID: 21491582
[TBL] [Abstract][Full Text] [Related]
3. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.
Rhee H; Nahm JH; Kim H; Choi GH; Yoo JE; Lee HS; Koh MJ; Park YN
Mod Pathol; 2016 Sep; 29(9):1038-49. PubMed ID: 27312064
[TBL] [Abstract][Full Text] [Related]
4. Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation.
Zeng Z; Ren J; O'Neil M; Zhao J; Bridges B; Cox J; Abdulkarim B; Schmitt TM; Kumer SC; Weinman SA
BMC Cancer; 2012 Dec; 12():584. PubMed ID: 23216644
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.
Matthai SM; Ramakrishna B
Indian J Med Res; 2015 Oct; 142(4):391-8. PubMed ID: 26609030
[TBL] [Abstract][Full Text] [Related]
6. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma.
Kim M; Hui KM; Shi M; Reau N; Aloman C
Hepatol Commun; 2022 Nov; 6(11):3247-3259. PubMed ID: 36097402
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition.
Ledaki I; McIntyre A; Wigfield S; Buffa F; McGowan S; Baban D; Li JL; Harris AL
Oncotarget; 2015 Aug; 6(23):19413-27. PubMed ID: 26305601
[TBL] [Abstract][Full Text] [Related]
9. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
[No Abstract] [Full Text] [Related]
10. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
[TBL] [Abstract][Full Text] [Related]
11. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
[TBL] [Abstract][Full Text] [Related]
12. TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma.
Sciarra A; Ronot M; Di Tommaso L; Raschioni C; Castera L; Belghiti J; Bedossa P; Vilgrain V; Roncalli M; Paradis V
Liver Int; 2015 Nov; 35(11):2466-73. PubMed ID: 25865109
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.
Nahm JH; Rhee H; Kim H; Yoo JE; San Lee J; Jeon Y; Choi GH; Park YN
Oncotarget; 2017 Nov; 8(59):99359-99371. PubMed ID: 29245907
[TBL] [Abstract][Full Text] [Related]
14. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
15. Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.
Zhang Q; Zhang CS; Xin Q; Ma Z; Liu GQ; Liu BB; Wang FM; Gao YT; Du Z
World J Gastroenterol; 2014 Aug; 20(31):10908-15. PubMed ID: 25152593
[TBL] [Abstract][Full Text] [Related]
16. Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy.
Farris AB; Dursun N; Dhanasekaran R; Coban I; McIntosh EB; Adsay NV; Kim HS
Pathol Res Pract; 2012 Jan; 208(1):15-21. PubMed ID: 22088254
[TBL] [Abstract][Full Text] [Related]
17. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
[TBL] [Abstract][Full Text] [Related]
19. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
Chan AW; Tong JH; Chan SL; Lai PB; To KF
Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
[TBL] [Abstract][Full Text] [Related]
20. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
